Global Innovation. Local Access.
50+
Countries Served
6,000+
Global Customers
1999
EGENS Established
Global Reach & Compliance
EGENS serves over 6,000 customers across more than 50 countries and regions. Their operations adhere to rigorous quality management systems including ISO 9001, ISO 14001, ISO 45001, and ISO 13485.
Nantong Yishi Biotechnology Co., Ltd.
Established in 1999, EGENS is a leading Chinese in-vitro diagnostics company. With over two decades of experience, they deliver multi-platform IVD technologies to healthcare providers globally.
Diverse Diagnostic Platforms
Immunochromatography
ELISA
Chemiluminescence
Molecular Diagnostics
Rapid and reliable tests for infectious diseases and other analytes, providing quick results at the point of care.
Enzyme-Linked Immunosorbent Assays for precise detection and quantification of antibodies, antigens, and proteins.
Advanced chemiluminescence immunoassays offering high sensitivity and specificity for critical diagnostic markers.
Cutting-edge molecular methods for accurate pathogen detection, genetic analysis, and personalized medicine solutions.
Expanding Our Partner Network
MedAxis is built on an extensible framework designed to onboard additional verified international IVD manufacturers. We continuously seek partners whose technologies align with Southern Africa's evolving healthcare needs.
Our rigorous vetting process ensures that every new partnership enhances our commitment to quality, regulatory compliance, and reliable distribution across the region. Product availability and regulatory status may vary by market.
Whether you are an international manufacturer seeking regional distribution or a healthcare institution requiring verified diagnostic solutions, our team is ready to assist.